Literature DB >> 9662288

The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period.

D Ahdoot1, K M Van Nostrand, N J Nguyen, D S Tewari, T Kurasaki, P J DiSaia, G S Rose.   

Abstract

OBJECTIVES: We sought to determine whether pregnant women with abnormal antepartum cervical cytologic findings differ in their postpartum rates of regression with respect to mode of delivery. STUDY
DESIGN: Between 1990 and 1997, 446 pregnant women with antepartum abnormal cervical cytologic findings were identified. Complete demographic, clinical, and cytologic reports were available for 138 women. Papanicolaou smear data were collected and separated into three groups by use of the Bethesda classification system (atypical squamous cells of undetermined significance, low-grade squamous intraepithelial cells, and high-grade intraepithelial cells). Postpartum regression rates of antepartum Papanicolaou smears, with respect to degree of squamous epithelial cell abnormality and mode of delivery, were analyzed by Fisher's exact and Wilcoxon rank sum tests.
RESULTS: Of the 138 women, 109 (79%) were delivered vaginally and 29 (21%) by cesarean section. No statistically significant difference was found between women delivered vaginally and those delivered by cesarean section with respect to age, parity, and smoking history within the three groups (atypical squamous cells of undetermined significance, low-grade squamous intraepithelial cells, and high-grade squamous intraepithelial cells). The overall postpartum regression rate for the 59 women with antepartum high-grade squamous intraepithelial cells was 48%. Of the 47 women with high-grade squamous intraepithelial cells who were delivered vaginally, 28 showed regression in the postpartum period versus none of the 12 women delivered by cesarean section (60% vs 0%, p < 0.0002).
CONCLUSION: Postpartum spontaneous regression of Papanicolaou smears consistent with high-grade squamous intraepithelial cells occurs with increased frequency among women who are delivered vaginally versus by cesarean section.

Entities:  

Mesh:

Year:  1998        PMID: 9662288     DOI: 10.1016/s0002-9378(98)70310-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

Authors:  Sileny N Han; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

2.  Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis.

Authors:  Rosa Freudenreich; Martin Weiss; Tobias Engler; Felix Neis; Melanie Henes
Journal:  Arch Gynecol Obstet       Date:  2022-08-17       Impact factor: 2.493

3.  Course of cervical intraepithelial neoplasia diagnosed during pregnancy.

Authors:  Donata Grimm; Isabelle Lang; Katharina Prieske; Anna Jaeger; Volkmar Müller; Sascha Kuerti; Eike Burandt; Susanne Lezius; Barbara Schmalfeldt; Linn Woelber
Journal:  Arch Gynecol Obstet       Date:  2020-04-22       Impact factor: 2.344

Review 4.  Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature.

Authors:  Mariella Mailath-Pokorny; Richard Schwameis; Christoph Grimm; Alexander Reinthaller; Stephan Polterauer
Journal:  BMC Pregnancy Childbirth       Date:  2016-04-07       Impact factor: 3.007

5.  The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.

Authors:  Fadimatu Bakari; Muhammad A Abdul; Saad A Ahmed
Journal:  Ann Afr Med       Date:  2017 Apr-Jun

6.  High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum.

Authors:  M A E Nobbenhuis; T J M Helmerhorst; A J C van den Brule; L Rozendaal; P D Bezemer; F J Voorhorst; C J L M Meijer
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

7.  Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.

Authors:  Helen Trottier; Marie-Hélène Mayrand; Maria Luiza Baggio; Lenice Galan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-07       Impact factor: 3.007

8.  HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.

Authors:  Emilia Moreira Jalil; Francisco Inacio Bastos; Patricia Pereira Dos Santos Melli; Geraldo Duarte; Renata Toscano Simoes; Aparecida Yulie Yamamoto; Rodrigo Augustus Amaral de Morais; Silvana Maria Quintana
Journal:  BMC Infect Dis       Date:  2013-12-01       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.